Moneycontrol PRO

business

Ranbaxy Q1 net falls 68% on weak sales, but beats forecast

Pharma major Ranbaxy Laboratories’ first quarter (January-March) net profit declined 68% year-on-year to Rs 304.39 crore due to a sharp drop in sales from outside India.

first published: May 10, 2011 05:15 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347